Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sun Pharma Advanced Research Company that it enclosed the Press Release titled ‘SPARC Announces Results from the Planned Interim Analysis of the PROSEEK Study of Vodobatinib in Patients with Early Parkinson’s Disease’, which the company will be releasing after sending this letter.
The above information is a part of company’s filings submitted to BSE.